
- The CEO of <strong>Novo Nordisk</strong> warned of the impact of tariffs on the pharmaceutical industry. Weight-loss drugs, including Ozempic and Wegovy, could cost more. Generic meds could also see price increases and perhaps shortages, he added.
Users of revolutionary weight-loss drugs may have to adjust their budgets or dosages in the near future, as the maker of Ozempic and Wegovy is warning tariffs could drive prices higher.